English

MyoKardia Inc

EDGAR

MYOK Quarterly report (10-Q) · filed 2020-11-05

60 filing records in this dataset, filed from 2015-09-28 to 2020-11-05. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

12.4 million USD

2018 Q4 · USD

Exact inputs and evidence

Revenue: 12400000 USD Source

Operating margin

-144.2%

2018 Q4 · %

Exact inputs and evidence

Operating Income: -73651000 USD Source
Operating Income: -55770000 USD Source
Revenue: 12400000 USD Source

Operating cash flow

-17.8 million USD

2018 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -64815000 USD Source
Operating Cash Flow: -47028000 USD Source

Free cash flow

-18.1 million USD

2018 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -64815000 USD Source
Operating Cash Flow: -47028000 USD Source
Capital Expenditure: 3373000 USD Source
Capital Expenditure: 3017000 USD Source

Cash and cash equivalents: 676 million USD 2020-09-30 Source
Exact value

675541000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 53.3 million shares 2020-09-30 Source
Exact value

53308689 shares

Reported share-count change

15.34% · 7.09 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

46218925 shares · 2019-09-30· Source
53308689 shares · 2020-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

33.6 million USD

2018-01-01 – 2018-12-31

Exact inputs and evidence

Revenue: 5331000 USD · 2018-01-01 – 2018-03-31 Source
Revenue: 6639000 USD · 2018-04-01 – 2018-06-30 Source
Revenue: 9188000 USD · 2018-07-01 – 2018-09-30 Source
Revenue: 12400000 USD · 2018-10-01 – 2018-12-31 Source

Net income

-277 million USD

2019-10-01 – 2020-09-30

Exact inputs and evidence

Net income: -276213000 USD · 2019-01-01 – 2019-12-31 Source
Net income: -217446000 USD · 2019-01-01 – 2019-09-30 Source
Net income: -69868000 USD · 2020-01-01 – 2020-03-31 Source
Net income: -63585000 USD · 2020-04-01 – 2020-06-30 Source
Net income: -84744000 USD · 2020-07-01 – 2020-09-30 Source

Operating cash flow

-195 million USD

2019-10-01 – 2020-09-30

Exact inputs and evidence

Operating cash flow: -241769000 USD · 2019-01-01 – 2019-12-31 Source
Operating cash flow: -188912000 USD · 2019-01-01 – 2019-09-30 Source
Operating cash flow: -59897000 USD · 2020-01-01 – 2020-03-31 Source
Operating cash flow: -112762000 USD · 2020-01-01 – 2020-06-30 Source
Operating cash flow: -59897000 USD · 2020-01-01 – 2020-03-31 Source
Operating cash flow: -142240000 USD · 2020-01-01 – 2020-09-30 Source
Operating cash flow: -112762000 USD · 2020-01-01 – 2020-06-30 Source

Capital expenditure

17.2 million USD

2019-10-01 – 2020-09-30

Exact inputs and evidence

Capital expenditure: 3264000 USD · 2019-01-01 – 2019-12-31 Source
Capital expenditure: 1978000 USD · 2019-01-01 – 2019-09-30 Source
Capital expenditure: 12627000 USD · 2020-01-01 – 2020-03-31 Source
Capital expenditure: 14019000 USD · 2020-01-01 – 2020-06-30 Source
Capital expenditure: 12627000 USD · 2020-01-01 – 2020-03-31 Source
Capital expenditure: 15875000 USD · 2020-01-01 – 2020-09-30 Source
Capital expenditure: 14019000 USD · 2020-01-01 – 2020-06-30 Source

Free cash flow

-212 million USD

2019-10-01 – 2020-09-30

Exact inputs and evidence

Operating cash flow: -241769000 USD · 2019-01-01 – 2019-12-31 Source
Operating cash flow: -188912000 USD · 2019-01-01 – 2019-09-30 Source
Operating cash flow: -59897000 USD · 2020-01-01 – 2020-03-31 Source
Operating cash flow: -112762000 USD · 2020-01-01 – 2020-06-30 Source
Operating cash flow: -59897000 USD · 2020-01-01 – 2020-03-31 Source
Operating cash flow: -142240000 USD · 2020-01-01 – 2020-09-30 Source
Operating cash flow: -112762000 USD · 2020-01-01 – 2020-06-30 Source
Capital expenditure: 3264000 USD · 2019-01-01 – 2019-12-31 Source
Capital expenditure: 1978000 USD · 2019-01-01 – 2019-09-30 Source
Capital expenditure: 12627000 USD · 2020-01-01 – 2020-03-31 Source
Capital expenditure: 14019000 USD · 2020-01-01 – 2020-06-30 Source
Capital expenditure: 12627000 USD · 2020-01-01 – 2020-03-31 Source
Capital expenditure: 15875000 USD · 2020-01-01 – 2020-09-30 Source
Capital expenditure: 14019000 USD · 2020-01-01 – 2020-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2020-11-05.

Financial data available through: 2019-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2019-12-31
Operating income: 7 of 11 periods available· newest 2019-12-31
Net income: 7 of 11 periods available· newest 2019-12-31
Operating cash flow: 7 of 11 periods available· newest 2019-12-31
Capital expenditure: 7 of 11 periods available· newest 2019-12-31
Total assets: 4 of 11 periods available· newest 2019-12-31
Total liabilities: 4 of 11 periods available· newest 2019-12-31
Current assets: 4 of 11 periods available· newest 2019-12-31
Current liabilities: 4 of 11 periods available· newest 2019-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2019-12-31
long term debt: No compatible figures in this window
Shares outstanding: 4 of 11 periods available· newest 2019-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-100%

Prior period

USD 33.56 million

2018-01-01 – 2018-12-31
Current period

USD 0

2019-01-01 – 2019-12-31

Exact inputs and evidence

0 − 33558000 = -33558000 USD

33558000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
0 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MyoKardia Inc · 2019-12-31 MyoKardia Inc (edgar:1552451) Year-over-year change in Revenue: -33558000 USD Concept: fundies:Revenue Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2577 Filing: 000156459020007418 Input fundies:Revenue: 33558000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#1841351 Filing: 000156459020007418
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 208.52 million

Prior period

−USD 67.7 million

2018-01-01 – 2018-12-31
Current period

−USD 276.21 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

-276213000 − -67698000 = -208515000 USD

-67698000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
-276213000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MyoKardia Inc · 2019-12-31 MyoKardia Inc (edgar:1552451) Year-over-year change in Net income: -208515000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -276213000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#3180013 Filing: 000156459020007418 Input fundies:NetIncome: -67698000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#3181883 Filing: 000156459020007418
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 176.95 million

Prior period

−USD 64.82 million

2018-01-01 – 2018-12-31
Current period

−USD 241.77 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

-241769000 − -64815000 = -176954000 USD

-64815000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
-241769000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MyoKardia Inc · 2019-12-31 MyoKardia Inc (edgar:1552451) Year-over-year change in Operating cash flow: -176954000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -241769000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2336391 Filing: 000156459020007418 Input fundies:OperatingCashFlow: -64815000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2338378 Filing: 000156459020007418
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-3.2%

Prior period

USD 3.37 million

2018-01-01 – 2018-12-31
Current period

USD 3.26 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

3264000 − 3373000 = -109000 USD

3373000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
3264000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MyoKardia Inc · 2019-12-31 MyoKardia Inc (edgar:1552451) Year-over-year change in Capital expenditure: -109000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3264000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2365137 Filing: 000156459020007418 Input fundies:CapitalExpenditure: 3373000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2366933 Filing: 000156459020007418
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2019-01-01 – 2019-12-31

Revenue USD 0
Operating costs Derived USD 287.83 million
Operating income −USD 287.83 million
Tax, interest and other Derived −USD 11.62 million
Net income −USD 276.21 million

Cash

Operating cash flow −USD 241.77 million
Capital expenditure USD 3.26 million
Free cash flow Derived −USD 245.03 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 125% of revenue.
2017 Operating loss: operating costs were 613% of revenue.
2018 Operating loss: operating costs were 319% of revenue.
2019 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	41971000	52504000 Derived	-10533000	-153000 Derived	-10380000	-21939000 Derived	Source 2016-01-01 – 2016-12-31: 41971000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -10533000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -10380000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -20856000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 1083000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	11442000	70109000 Derived	-58667000	-1657000 Derived	-57010000	-11355000 Derived	Source 2017-01-01 – 2017-12-31: 11442000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -58667000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -57010000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -9838000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 1517000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	33558000	107209000 Derived	-73651000	-5953000 Derived	-67698000	-68188000 Derived	Source 2018-01-01 – 2018-12-31: 33558000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -73651000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -67698000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -64815000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 3373000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	0	287834000 Derived	-287834000	-11621000 Derived	-276213000	-245033000 Derived	Source 2019-01-01 – 2019-12-31: 0 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -287834000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -276213000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -241769000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 3264000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	41971000	Revenue: 41971000 Open source
20172017-12-31	Revenue	11442000	Revenue: 11442000 Open source
20182018-12-31	Revenue	33558000	Revenue: 33558000 Open source
20192019-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 41971000 Open source
20172017-12-31	Year over year	-72.7%	Revenue: 11442000 Open source Revenue: 41971000 Open source
20182018-12-31	Year over year	193.3%	Revenue: 33558000 Open source Revenue: 11442000 Open source
20192019-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 33558000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -219.5% 2018

Net margin -201.7% 2018

Free cash flow margin -203.2% 2018

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-25.1%	Operating Income: -10533000 Open source Revenue: 41971000 Open source
20172017-12-31	Operating margin	-512.7%	Operating Income: -58667000 Open source Revenue: 11442000 Open source
20182018-12-31	Operating margin	-219.5%	Operating Income: -73651000 Open source Revenue: 33558000 Open source
20192019-12-31	Operating margin	Not reported	Operating Income: -287834000 Open source Revenue: 0 Open source
20162016-12-31	Net margin	-24.7%	Net Income: -10380000 Open source Revenue: 41971000 Open source
20172017-12-31	Net margin	-498.3%	Net Income: -57010000 Open source Revenue: 11442000 Open source
20182018-12-31	Net margin	-201.7%	Net Income: -67698000 Open source Revenue: 33558000 Open source
20192019-12-31	Net margin	Not reported	Net Income: -276213000 Open source Revenue: 0 Open source
20162016-12-31	Free cash flow margin	-52.3%	Revenue: 41971000 Open source Operating Cash Flow: -20856000 Open source Capital Expenditure: 1083000 Open source
20172017-12-31	Free cash flow margin	-99.2%	Revenue: 11442000 Open source Operating Cash Flow: -9838000 Open source Capital Expenditure: 1517000 Open source
20182018-12-31	Free cash flow margin	-203.2%	Revenue: 33558000 Open source Operating Cash Flow: -64815000 Open source Capital Expenditure: 3373000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -241769000 Open source Capital Expenditure: 3264000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -241.8M 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-20856000	Operating Cash Flow: -20856000 Open source
20172017-12-31	Operating cash flow	-9838000	Operating Cash Flow: -9838000 Open source
20182018-12-31	Operating cash flow	-64815000	Operating Cash Flow: -64815000 Open source
20192019-12-31	Operating cash flow	-241769000	Operating Cash Flow: -241769000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -245M 2019

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-21939000	Operating Cash Flow: -20856000 Open source Capital Expenditure: 1083000 Open source
20172017-12-31	Free cash flow	-11355000	Operating Cash Flow: -9838000 Open source Capital Expenditure: 1517000 Open source
20182018-12-31	Free cash flow	-68188000	Operating Cash Flow: -64815000 Open source Capital Expenditure: 3373000 Open source
20192019-12-31	Free cash flow	-245033000	Operating Cash Flow: -241769000 Open source Capital Expenditure: 3264000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

10.9% 2019

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	27.8%	Total Liabilities: 55924000 Open source Total Assets: 201306000 Open source
20172017-12-31	Liabilities / assets	18.4%	Total Liabilities: 52132000 Open source Total Assets: 282808000 Open source
20182018-12-31	Liabilities / assets	9%	Total Liabilities: 36686000 Open source Total Assets: 407253000 Open source
20192019-12-31	Liabilities / assets	10.9%	Total Liabilities: 49820000 Open source Total Assets: 456094000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

8.85× 2019

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	5.65×	Current Assets: 186263000 Open source Current Liabilities: 32988000 Open source
20172017-12-31	Current assets / current liabilities	5×	Current Assets: 259393000 Open source Current Liabilities: 51930000 Open source
20182018-12-31	Current assets / current liabilities	8.71×	Current Assets: 319446000 Open source Current Liabilities: 36677000 Open source
20192019-12-31	Current assets / current liabilities	8.85×	Current Assets: 423836000 Open source Current Liabilities: 47912000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	−USD 12.7 million Exact value Exact value: -12700000 USD 2013-01-01 – 2013-12-31: -12700000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MyoKardia Inc · 2013-12-31 MyoKardia Inc (edgar:1552451) Net Income: -12700000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12700000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459016015044/myok-20151231.xml#116352 Filing: 000156459016015044 The citation records this snapshot. The page link may show a newer release later.	−USD 12.53 million Exact value Exact value: -12531000 USD 2013-01-01 – 2013-12-31: -12531000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MyoKardia Inc · 2013-12-31 MyoKardia Inc (edgar:1552451) Operating Cash Flow: -12531000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12531000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459016015044/myok-20151231.xml#156109 Filing: 000156459016015044 The citation records this snapshot. The page link may show a newer release later.	USD 1.17 million Exact value Exact value: 1169000 USD 2013-01-01 – 2013-12-31: 1169000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MyoKardia Inc · 2013-12-31 MyoKardia Inc (edgar:1552451) Capital Expenditure: 1169000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1169000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459016015044/myok-20151231.xml#156780 Filing: 000156459016015044 The citation records this snapshot. The page link may show a newer release later.	−USD 13.7 million Calculation and evidence -12531000 − 1169000 USD Exact free cash flow: -13700000 USD 2013-01-01 – 2013-12-31: -12531000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 1169000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MyoKardia Inc · 2013-12-31 MyoKardia Inc (edgar:1552451) Free cash flow: -13700000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12531000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459016015044/myok-20151231.xml#156109 Filing: 000156459016015044 Input fundies:CapitalExpenditure: 1169000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459016015044/myok-20151231.xml#156780 Filing: 000156459016015044 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 16.83 million Exact value Exact value: -16829000 USD 2014-01-01 – 2014-12-31: -16829000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MyoKardia Inc · 2014-12-31 MyoKardia Inc (edgar:1552451) Net Income: -16829000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16829000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459017004088/myok-20161231.xml#121903 Filing: 000156459017004088 The citation records this snapshot. The page link may show a newer release later.	USD 13.66 million Exact value Exact value: 13658000 USD 2014-01-01 – 2014-12-31: 13658000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MyoKardia Inc · 2014-12-31 MyoKardia Inc (edgar:1552451) Operating Cash Flow: 13658000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 13658000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459017004088/myok-20161231.xml#163838 Filing: 000156459017004088 The citation records this snapshot. The page link may show a newer release later.	USD 716,000 Exact value Exact value: 716000 USD 2014-01-01 – 2014-12-31: 716000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MyoKardia Inc · 2014-12-31 MyoKardia Inc (edgar:1552451) Capital Expenditure: 716000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 716000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459017004088/myok-20161231.xml#164692 Filing: 000156459017004088 The citation records this snapshot. The page link may show a newer release later.	USD 12.94 million Calculation and evidence 13658000 − 716000 USD Exact free cash flow: 12942000 USD 2014-01-01 – 2014-12-31: 13658000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 716000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MyoKardia Inc · 2014-12-31 MyoKardia Inc (edgar:1552451) Free cash flow: 12942000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 13658000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459017004088/myok-20161231.xml#163838 Filing: 000156459017004088 Input fundies:CapitalExpenditure: 716000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459017004088/myok-20161231.xml#164692 Filing: 000156459017004088 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 22.95 million Exact value Exact value: -22946000 USD 2015-01-01 – 2015-12-31: -22946000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MyoKardia Inc · 2015-12-31 MyoKardia Inc (edgar:1552451) Net Income: -22946000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22946000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459018004940/myok-20171231.xml#123289 Filing: 000156459018004940 The citation records this snapshot. The page link may show a newer release later.	−USD 32.1 million Exact value Exact value: -32100000 USD 2015-01-01 – 2015-12-31: -32100000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MyoKardia Inc · 2015-12-31 MyoKardia Inc (edgar:1552451) Operating Cash Flow: -32100000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32100000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459018004940/myok-20171231.xml#159340 Filing: 000156459018004940 The citation records this snapshot. The page link may show a newer release later.	USD 1.45 million Exact value Exact value: 1446000 USD 2015-01-01 – 2015-12-31: 1446000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MyoKardia Inc · 2015-12-31 MyoKardia Inc (edgar:1552451) Capital Expenditure: 1446000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1446000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459018004940/myok-20171231.xml#160748 Filing: 000156459018004940 The citation records this snapshot. The page link may show a newer release later.	−USD 33.55 million Calculation and evidence -32100000 − 1446000 USD Exact free cash flow: -33546000 USD 2015-01-01 – 2015-12-31: -32100000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 1446000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MyoKardia Inc · 2015-12-31 MyoKardia Inc (edgar:1552451) Free cash flow: -33546000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32100000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459018004940/myok-20171231.xml#159340 Filing: 000156459018004940 Input fundies:CapitalExpenditure: 1446000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459018004940/myok-20171231.xml#160748 Filing: 000156459018004940 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 10.38 million Exact value Exact value: -10380000 USD 2016-01-01 – 2016-12-31: -10380000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MyoKardia Inc · 2016-12-31 MyoKardia Inc (edgar:1552451) Net Income: -10380000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10380000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459019005543/myok-20181231.xml#118237 Filing: 000156459019005543 The citation records this snapshot. The page link may show a newer release later.	−USD 20.86 million Exact value Exact value: -20856000 USD 2016-01-01 – 2016-12-31: -20856000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MyoKardia Inc · 2016-12-31 MyoKardia Inc (edgar:1552451) Operating Cash Flow: -20856000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20856000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459019005543/myok-20181231.xml#149676 Filing: 000156459019005543 The citation records this snapshot. The page link may show a newer release later.	USD 1.08 million Exact value Exact value: 1083000 USD 2016-01-01 – 2016-12-31: 1083000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MyoKardia Inc · 2016-12-31 MyoKardia Inc (edgar:1552451) Capital Expenditure: 1083000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1083000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459019005543/myok-20181231.xml#151599 Filing: 000156459019005543 The citation records this snapshot. The page link may show a newer release later.	−USD 21.94 million Calculation and evidence -20856000 − 1083000 USD Exact free cash flow: -21939000 USD 2016-01-01 – 2016-12-31: -20856000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 1083000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MyoKardia Inc · 2016-12-31 MyoKardia Inc (edgar:1552451) Free cash flow: -21939000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20856000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459019005543/myok-20181231.xml#149676 Filing: 000156459019005543 Input fundies:CapitalExpenditure: 1083000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459019005543/myok-20181231.xml#151599 Filing: 000156459019005543 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 57.01 million Exact value Exact value: -57010000 USD 2017-01-01 – 2017-12-31: -57010000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MyoKardia Inc · 2017-12-31 MyoKardia Inc (edgar:1552451) Net Income: -57010000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -57010000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#3183752 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.	−USD 9.84 million Exact value Exact value: -9838000 USD 2017-01-01 – 2017-12-31: -9838000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MyoKardia Inc · 2017-12-31 MyoKardia Inc (edgar:1552451) Operating Cash Flow: -9838000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9838000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2340364 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.	USD 1.52 million Exact value Exact value: 1517000 USD 2017-01-01 – 2017-12-31: 1517000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MyoKardia Inc · 2017-12-31 MyoKardia Inc (edgar:1552451) Capital Expenditure: 1517000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1517000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2368729 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.	−USD 11.36 million Calculation and evidence -9838000 − 1517000 USD Exact free cash flow: -11355000 USD 2017-01-01 – 2017-12-31: -9838000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 1517000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MyoKardia Inc · 2017-12-31 MyoKardia Inc (edgar:1552451) Free cash flow: -11355000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9838000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2340364 Filing: 000156459020007418 Input fundies:CapitalExpenditure: 1517000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2368729 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 67.7 million Exact value Exact value: -67698000 USD 2018-01-01 – 2018-12-31: -67698000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MyoKardia Inc · 2018-12-31 MyoKardia Inc (edgar:1552451) Net Income: -67698000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -67698000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#3181883 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.	−USD 64.82 million Exact value Exact value: -64815000 USD 2018-01-01 – 2018-12-31: -64815000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MyoKardia Inc · 2018-12-31 MyoKardia Inc (edgar:1552451) Operating Cash Flow: -64815000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -64815000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2338378 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.	USD 3.37 million Exact value Exact value: 3373000 USD 2018-01-01 – 2018-12-31: 3373000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MyoKardia Inc · 2018-12-31 MyoKardia Inc (edgar:1552451) Capital Expenditure: 3373000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3373000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2366933 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.	−USD 68.19 million Calculation and evidence -64815000 − 3373000 USD Exact free cash flow: -68188000 USD 2018-01-01 – 2018-12-31: -64815000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 3373000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MyoKardia Inc · 2018-12-31 MyoKardia Inc (edgar:1552451) Free cash flow: -68188000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -64815000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2338378 Filing: 000156459020007418 Input fundies:CapitalExpenditure: 3373000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2366933 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 276.21 million Exact value Exact value: -276213000 USD 2019-01-01 – 2019-12-31: -276213000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MyoKardia Inc · 2019-12-31 MyoKardia Inc (edgar:1552451) Net Income: -276213000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -276213000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#3180013 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.	−USD 241.77 million Exact value Exact value: -241769000 USD 2019-01-01 – 2019-12-31: -241769000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MyoKardia Inc · 2019-12-31 MyoKardia Inc (edgar:1552451) Operating Cash Flow: -241769000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -241769000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2336391 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.	USD 3.26 million Exact value Exact value: 3264000 USD 2019-01-01 – 2019-12-31: 3264000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MyoKardia Inc · 2019-12-31 MyoKardia Inc (edgar:1552451) Capital Expenditure: 3264000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3264000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2365137 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.	−USD 245.03 million Calculation and evidence -241769000 − 3264000 USD Exact free cash flow: -245033000 USD 2019-01-01 – 2019-12-31: -241769000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 3264000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MyoKardia Inc · 2019-12-31 MyoKardia Inc (edgar:1552451) Free cash flow: -245033000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:28:29Z Snapshot: b5b13cdaa3de5d2ce7268d805bfab8c0c0d6ea620f51ad83f2ae051ce9f04d9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1552451?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -241769000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2336391 Filing: 000156459020007418 Input fundies:CapitalExpenditure: 3264000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1552451/000156459020007418/myok-10k_20191231.htm#2365137 Filing: 000156459020007418 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

60 filings · 1,302 latest values · 1,302 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001552451, 1552451, MYOK, edgar:1552451

Also known as MYOKARDIA, INC., MYOKARDIA, INC., MyoKardia Inc, MyoKardia, Inc.

MyoKardia Inc

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2019 2019-01-01 – 2019-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation